Quick navigation menu :
  1. Go to content
  2. Go to the main sections menu
  3. Go to the subsections menu
  4. Go to the search engine
  5. Go to the languages menu
  6. Go to the help menu
  7. Go to the slots
  8. Go to contact slot
You are here:
  1. Home
  2. > Press room
  3. > Press packs
  4. > By area
  5. > Cardiovascular diseases / Thrombosis
Languages menu :
 

Contacts

Press Relations
Tel. :
(33) 1 53 77 4450
Fax :
(33) 1 53 77 4622
Adress :
174, avenue de France
75013 PARIS
FRANCE
Switchboard :
(33) 1 53 77 4000
 Content :

Press packs Cardiovascular diseases / Thrombosis

Attention(temp en dur) Les communiqués et dossiers de presse sont destinés aux journalistes, aux investisseurs potentiels et aux actionnaires  

December 12, 2006 New highlights in the prevention of the Venous Thromboembolism after Acute Ischemic Stroke: results of the PREVAIL study (ASH)

November 20, 2002 New perspectives on the long-term reduction of ischemic events post coronary intervention.

September 2, 2002 New horizons for clopidogrel in the treatment of atherothrombosis.

May 29, 2002 Role of Clopidogrel in the long-term prevention of ischemic stroke (MATCH Study)

March 18, 2002 New perspectives on Clopidogrel in the management of acute and long-term risks of atherothrombosis.

November 13, 2000 The New Frontier: Exploring the Potential of Clopidogrel as Cornerstone Therapy in Atherothrombosis Management

May 30, 2000 The role of Diltiazem Once Daily in the reduction of morbidity and mortality in hypertensive patients

May 29, 2000 Proven differences among AIIRAs: new evidence for irbesartan

May 4, 2000 New insights into the Epidemiology and Real-Life Implications of Atherothrombosis and PAD

March 13, 2000 New insights into the Efficacy and Safety of Clopidogrel in Coronary Stenting

March 12, 2000 Atherothrombosis: a major public health issue. Clopidogrel: new data, implications and perspectives

© sanofi-aventis 2004-2008 | Legal notice | Update: July 11, 2008